GOALS & OBJECTIVES
Emerging Technologies in Chronic Pain Pharmacotherapies
Including summaries from a symposium held in conjunction with AMCP's 21st Annual Meeting & Showcase in Orlando, Florida
Activity Date: July 2009  — Activity Info: Volume6, (1)
Goals & Objectives | Faculty | Complete Pre-Test Activity | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

GOAL
To provide managed care pharmacists with up-to-date information regarding their role in the management and treatment of patients with chronic pain.

TARGET AUDIENCE
This activity is designed for managed care pharmacists. No prerequisites required.

LEARNING OBJECTIVES
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:

  • Identify underlying contributors to chronic pain.
  • Identify barriers associated with opioid therapy and methods to overcome these obstacles to optimize treatment.
  • Differentiate between new and emerging treatment options relating to abuse-resistant technologies.
  • Manage symptom control and improve quality of life in patients with refractory pain.
  • Implement newly acquired knowledge and skills to optimize patient care (eg, equianalgesic conversion).

ACCREDITATION STATEMENT
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.

CREDIT DESIGNATION STATEMENT
acpe logoThis application-based activity is sponsored by The University of Tennessee College of Pharmacy who is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this activity will provide 1 contact hour credit (0.1 CEU). Successful completion includes reading the materials, completing the post-test with a score of at least 70%, and completing the course evaluation. If you score less than 70% on the post-test, you will be allowed to complete the post-test 1 more time. A statement of CE credit will be available online immediately following successful completion of the activity. ACPE program # 064-000-09-202-H01-P.

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity: 1 hour.

Release date: July 15, 2009. Expiration date: July 15, 2011.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of The University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

GRIEVANCE POLICY
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an activity sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This activity is supported by an educational grant from King Pharmaceuticals, Inc.

     
Home | Contact Us | View Account | Need Help?